 was
equivalent to aspirin alone in preventing vascular events in
patients with a prior stroke, TIA, or other cardiovascular
disease or in patients with high risk for cardiovascular
disease.
Antiplatelet agents are therefore recommended for patients with non-cardioembolic ischemic stroke or TIA associated with carotid atherosclerosis. Aspirin (50-325 mg/
d), the combination of aspirin and extended-release
dipyridamole,